Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-amino-6-methoxy-1-phenylpyridazinium Methylsulfate
2. Amezinium
3. Amezinium Chloride
4. Amezinium Methyl Sulfate
5. Amezinium Metisulfate
6. Amezinium Triflouoacetate Salt (1:1)
7. Lu 1631
8. Regulton
9. Supratonin
1. 30578-37-1
2. Amezinium Methylsulfate
3. Amezinium Methyl Sulfate
4. Supratonin
5. Regulton
6. Amezinium (methylsulfate)
7. Amezinii Metilsulfas
8. Risumic
9. Metilsulfate D'amezinium
10. Metilsulfato De Amezinio
11. 4-amino-6-methoxy-1-phenylpyridazin-1-ium Methyl Sulfate
12. Lu 1631
13. Amezinium Metilsulphate
14. 4-amino-6-methoxy-1-phenylpyridazinium Methyl Sulfate
15. Lu-1631
16. 03nr868icx
17. Pyridazinium, 4-amino-6-methoxy-1-phenyl-, Methyl Sulfate
18. Amezinium Metilsulfate;lu-1631
19. Amezinium Metilsulfate (jan)
20. 6-methoxy-1-phenylpyridazin-1-ium-4-amine;methyl Sulfate
21. Amezinium Metilsulfate [jan]
22. Ameziniummetilsulfat
23. Ameziniummetilsulfat [german]
24. Amezinio Metilsulfato
25. Amezinio Metilsulfato [spanish]
26. Amezinii Metilsulfas [inn-latin]
27. Amezinium Metilsulfate [inn:jan]
28. Einecs 250-248-0
29. Metilsulfate D'amezinium [inn-french]
30. Metilsulfato De Amezinio [inn-spanish]
31. Unii-03nr868icx
32. Amezinin
33. Dialead
34. Epinotec
35. Parcekion
36. Risumelic
37. Rizmylate
38. Rizumile
39. Solmfurin
40. Tenfortan
41. Acomic
42. Amegyl
43. Metroc
44. Upfree
45. Ofvit
46. Risumic (tn)
47. 4-amino-6-methoxy-1-phenylpyridazinium-methylsulfat [german]
48. Schembl309661
49. 4-amino-6-methoxy-1-phenylpyridazinium-methylsulfat
50. Chembl2106667
51. Chebi:31201
52. 6-methoxy-1-phenylpyridazin-1-ium-4-amine,methyl Sulfate
53. Dtxsid00184657
54. Hy-a0275
55. Amezinium Metilsulfate [inn]
56. Mfcd00865972
57. Amezinium Methyl Sulfate [mi]
58. Amezinium Metilsulfate [mart.]
59. Amezinium Metilsulfate [who-dd]
60. Cs-5554
61. Db13330
62. S11901
63. Ds-14012
64. Ft-0703448
65. D01304
66. A911631
67. 4-amino-6-methoxy-1-phenylpyridaziniummethylsulfate
68. 4-amino-6-methoxy-1-phenyl-pyridazinium Methyl Sulfate
69. 6-methoxy-1-phenylpyridazin-1-ium-4-amine Methylsulfate
| Molecular Weight | 313.33 g/mol |
|---|---|
| Molecular Formula | C12H15N3O5S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 313.07324176 g/mol |
| Monoisotopic Mass | 313.07324176 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 285 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Monoamine Oxidase Inhibitors
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
C - Cardiovascular system
C01 - Cardiac therapy
C01C - Cardiac stimulants excl. cardiac glycosides
C01CA - Adrenergic and dopaminergic agents
C01CA25 - Amezinium metilsulfate
ABOUT THIS PAGE
A Supratonin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Supratonin, including repackagers and relabelers. The FDA regulates Supratonin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Supratonin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Supratonin supplier is an individual or a company that provides Supratonin active pharmaceutical ingredient (API) or Supratonin finished formulations upon request. The Supratonin suppliers may include Supratonin API manufacturers, exporters, distributors and traders.
click here to find a list of Supratonin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Supratonin Drug Master File in Japan (Supratonin JDMF) empowers Supratonin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Supratonin JDMF during the approval evaluation for pharmaceutical products. At the time of Supratonin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Supratonin suppliers with JDMF on PharmaCompass.
Supratonin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Supratonin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Supratonin GMP manufacturer or Supratonin GMP API supplier for your needs.
A Supratonin CoA (Certificate of Analysis) is a formal document that attests to Supratonin's compliance with Supratonin specifications and serves as a tool for batch-level quality control.
Supratonin CoA mostly includes findings from lab analyses of a specific batch. For each Supratonin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Supratonin may be tested according to a variety of international standards, such as European Pharmacopoeia (Supratonin EP), Supratonin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Supratonin USP).
LOOKING FOR A SUPPLIER?
